Sensyne proposes London IPO

Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO on the London Stock Exchange's AIM market. The company expects to begin trading on Aug. 17.

Sensyne uses artificial intelligence to analyze clinical and patient data to speed up drug discovery and improve patient care through the development of new digital tools. The company has partnered with one undisclosed pharmaceutical company to use its technology for drug development, and plans to collaborate with additional companies...